Intrathecal xenogeneic chromaffin cell grafts reduce nociceptive behavior in a rodent tonic pain model

Experimental Neurology

Volumn 186, Issue 2, 2004, Pages 198-211

  Sol, J C ^a   Sallerin, B ^a   Larrue, S ^b   Li, R Y ^a   Jozan, S ^a   Tortosa, F ^a   Mascott, C ^a   Carraoue, F ^a   Tafani, M ^c   Lazorthes, Y ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c CHU PURPAN   (France)

Author keywords

Cellular therapy; Formalin test; Intrathecal transplantation; Nociception and analgesia; Porcine and bovine chromaffin cells; Xenogeneic source

Indexed keywords

FORMALDEHYDE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CATTLE; CELL ISOLATION; CELL SURVIVAL; CELL TRANSPLANTATION; CHROMAFFIN CELL; CONTROLLED STUDY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; SUBARACHNOID SPACE; SWINE; XENOGRAFT;

ADRENAL MEDULLA; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CATECHOLAMINES; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; CHROMOGRANIN A; CHROMOGRANINS; DISEASE MODELS, ANIMAL; DOPAMINE BETA-HYDROXYLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, METHIONINE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; PAIN MEASUREMENT; PAIN, INTRACTABLE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID SPACE; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 12144286224     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.10.018     Document Type: Article

References (51)

1. Abbott F.V., Franklin K.B., Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain. 60:1995;91-102.
2. Aebischer P., Buchser E., Joseph J.M., Favre J., de Tribolet N., Lysaght M., Rudnick S., Goddard M. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. Transplantation. 58:1994;1275-1277.
3. Bader M.F., Ciesielski-Treska J., Thierse D., Hesketh J.E., Aunis D. Immunocytochemical study of microtubules in chromaffin cells in culture and evidence that tubulin is not an integral protein of the chromaffin granule membrane. J. Neurochem. 37:1981;917-933.
4. Bader M.F., Holz R.W., Kumakura K., Vitale N. Exocytosis: the chromaffin cell as a model system. Ann. N. Y. Acad. Sci. 971:2002;178-183.
5. Bes J.C., Tkaczuk J., Czech K.A., Tafani M., Bastide R., Caratero C., Pappas G.D., Lazorthes Y. One-year chromaffin cell allograft survival in cancer patients with chronic pain: morphological and functional evidence. Cell Transplant. 7:1998;227-238.
6. Borie D.C., Cramer D.V., Phan-Thanh L., Vaillant J.C., Bequet J.L., Makowka L., Hannoun L. Microbiological hazards related to xenotransplantation of porcine organs into man. Infect. Control Hosp. Epidemiol. 19:1998;355-365.
7. Clive P., Scobie L., Quinn G. Porcine endogenous retrovirus - Advances, issues and solutions. Xenotransplantation. 9:2002;373-375.
8. Czech K.A., Sagen J. Update on cellular transplantation into the CNS as a novel therapy for chronic pain. Prog. Neurobiol. 46:1995;507-529.
9. Doupe A.J., Landis S.C., Patterson P.H. Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity. J. Neurosci. 5:1985;2119-2142.
10. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
11. Duplan H., Bes J.C., Tafani M., Sallerin B., Sagen J., Ohayon E., Lazorthes Y., Tkaczuk J. Adrenal medullary explants as an efficient tool for pain control: adhesive biomolecular components are involved in graft function ex vivo. Exp. Neurol. 163:2000;331-347.
12. Ginzburg R., Seltzer Z. Subarachnoid spinal cord transplantation of adrenal medulla suppresses chronic neuropathic pain behavior in rats. Brain Res. 523:1990;147-150.
13. Goddard M.J., Foweraker J.E., Wallwork J. Xenotransplantation - 2000. J. Clin. Pathol. 53:2000;44-48.
14. Gulwadi A.G., Hoane M.R., Saydoff J.A., Frydel B.R., Lindner M.D. No detectable analgesic effects in the formalin test even with one million bovine adrenal chromaffin cells. Pain. 99:2002;263-271.
15. Hains B.C., Chastain K.M., Everhart A.W., McAdoo D.J., Hulsebosch C.E. Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury. Exp. Neurol. 164:2000;426-437.
16. Hama A.T., Sagen J. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space. Brain Res. 651:1994;183-193.
17. Hentall I.D., Sagen J. The alleviation of pain by cell transplantation. Prog. Brain Res. 127:2000;535-550.
18. Kilpatrick D.L., Ledbetter F.H., Carson K.A., Kirshner A.G., Slepetis R., Kirshner N. Stability of bovine adrenal medulla cells in culture. J. Neurochem. 35:1980;679-692.
19. Lazorthes Y., Sagen J., Sallerin B., Tkaczuk J., Duplan H., Sol J.C., Tafani M., Bes J.C. Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain. 87:2000;19-32.
20. Lindner M.D., Francis J.M., McDermott P.E., Bell W.J., Blaney T.J., Sherman S.S., Saydoff J.A. Numerous adrenal chromaffin cell preparations fail to produce analgesic effects in the formalin test or in tests of acute pain even with nicotine stimulation. Pain. 88:2000;177-188.
21. Lindner M.D., Francis J.M., Saydoff J.A. Intrathecal polymer- encapsulated bovine adrenal chromaffin cells fail to produce analgesic effects in the hotplate and formalin test. Exp. Neurol. 165:2000;370-383.
22. Livett B.G., Dean D.M., Whelan L.G., Udenfriend S., Rossier J. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature. 289:1981;317-319.
23. Mercier P., Fernandez F., Tortosa F., Bagheri H., Duplan H., Tafani M., Bes J.C., Bastide R., Lazorthes Y., Sallerin B. A new method for encapsulation of living cells: preliminary results with PC12 cell line. J. Microencapsulation. 18:2001;323-334.
24. Michalewicz P., Laurito C.E., Pappas G.D., Lu Y., Yeomans D.C. Purification of adrenal chromaffin cells increases antinociceptive efficacy of xenotransplants without immunosuppression. Cell Transplant. 8:1999;103-109.
25. Nottle M.B., D'Apice A.J., Cowan P.J., Boquest A.C., Harrison S.J., Grupen C.G. Transgenic perspectives in xenotransplantation. Xenotransplantation. 9:2001;305-308.
26. Onions D., Cooper D.K., Alexander T.J., Brown C., Claasen E., Foweraker J.E., Harris D.L., Mahy B.W., Minor P.D., Osterhaus A.D., Pastoret P.P., Yamanouchi K. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation. 7:2000;143-155.
27. Onofrio B.M., Yaksh T.L. Long-term relief of pain produced by intrathecal morphine infusion in 53 patients. J. Neurosurg. 72:1990;200-209.
28. Ortega J.D., Sagen J., Pappas G.D. Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS. Cell Transplant. 1:1992;33-41.
29. Ortega J.D., Sagen J., Pappas G.D. Survival and integration of bovine chromaffin cells transplanted into rat central nervous system without exogenous trophic factors. J. Comp. Neurol. 323:1992;13-24.
30. Pappas G.D., Lazorthes Y., Bes J.C., Tafani M., Winnie A.P. Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers. Neurol. Res. 19:1997;71-77.
31. Ricordi C., Cryer P.E., Lacy P.E. Effect of in vitro culture and cyclosporine A treatment on adrenal medullary graft survival. J. Surg. Res. 47:1989;20-23.
32. Sagen J., Kemmler J.E. Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants. Brain Res. 502:1989;1-10.
33. Sagen J., Pappas G.D., Perlow M.J. Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity. Brain Res. 384:1986;189-194.
34. Sagen J., Pappas G.D., Pollard H.B. Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc. Natl. Acad. Sci. U. S. A. 83:1986;7522-7526.
35. Sagen J., Wang H., Pappas G.D. Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. Pain. 42:1990;69-79.
36. Sagen J., Kemmler J.E., Wang H. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J. Neurochem. 56:1991;623-627.
37. Sallerin-Caute B., Lazorthes Y., Deguine O., Frances B., Verdie J.C., Charlet J.P., Bastide R. Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance? Neurosurgery. 42:1998;44-49. (discussion 49-50).
38. Siegan J.B., Sagen J. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain. 70:1997;279-285.
39. Unsicker K. The trophic cocktail made by adrenal chromaffin cells. Exp. Neurol. 123:1993;167-173.
40. Vaquero J., Arias A., Oya S., Zurita M. Chromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats. NeuroReport. 2:1991;149-151.
41. Vizzardelli C., Potter E.D., Berney T., Pileggi A., Inverardi L., Ricordi C., Sagen J. Automated method for isolation of adrenal medullary chromaffin cells from neonatal porcine glands. Cell Transplant. 10:2001;689-696.
42. Wang H., Sagen J. Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharmacology. 33:1994;681-692.
43. Wang H., Sagen J. Optimization of adrenal medullary allograft conditions for pain alleviation. J. Neural Transpl. Plast. 5:1994;49-64.
44. Watson G.S., Sufka K.J., Coderre T.J. Optimal scoring strategies and weights for the formalin test in rats. Pain. 70:1997;53-58.
45. Wiertelak E.P., Furness L.E., Horan R., Martinez J., Maier S.F., Watkins L.R. Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via the NMDA-nitric oxide cascade. Brain Res. 649:1994;19-26.
46. Wilson S.P., Viveros O.H. Primary culture of adrenal medullary chromaffin cells in a chemically defined medium. Exp. Cell Res. 133:1981;159-169.
47. Winnie A.P., Pappas G.D., Das Gupta T.K., Wang H., Ortega J.D., Sagen J. Subarachnoid adrenal medullary transplants for terminal cancer pain. A report of preliminary studies. Anesthesiology. 79:1993;644-653.
48. Xu Y.P., Duarte E.P., Forsberg E.J. Calcium dependency of muscarinic and nicotinic agonist-induced ATP and catecholamine secretion from porcine adrenal chromaffin cells. J. Neurochem. 56:1991;1889-1896.
49. Yeomans D.C., Lu Y., Pappas G.D. Conditional analgesia from spinally transplanted adrenal chromaffin cells. Pain. 95:2002;191-194.
50. Yu W., Hao J.X., Xu X.J., Saydoff J., Haegerstrand A., Hokfelt T., Wiesenfeld-Hallin Z. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Pain. 74:1998;115-122.
51. Zimmermann M. Ethical guidelines for investigators of experimental pain in conscious animals. Pain. 16:1983;109-110.